+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Alosetron"

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024 - Product Thumbnail Image

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Irritable Bowel Syndrome Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Irritable Bowel Syndrome Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • December 2023
  • 259 Pages
  • Global
Irritable Bowel Syndrome with Diarrhea Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Irritable Bowel Syndrome with Diarrhea Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 120 Pages
  • Global
From
Alosetron hydrochloride (CAS 122852-69-1) Global Market Research Report 2024 - Product Thumbnail Image

Alosetron hydrochloride (CAS 122852-69-1) Global Market Research Report 2024

  • Report
  • April 2024
  • 50 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Alosetron is a drug used to treat severe diarrhea-predominant irritable bowel syndrome (IBS-D) in women. It is a 5-HT3 receptor antagonist, meaning it blocks the action of serotonin, a neurotransmitter that can cause diarrhea. Alosetron is used to reduce the frequency and severity of abdominal pain and diarrhea associated with IBS-D. It is not recommended for use in men due to the risk of serious side effects. The Alosetron market is composed of pharmaceutical companies that manufacture and distribute the drug. These companies are responsible for the research and development of the drug, as well as its marketing and distribution. They also provide information about the drug to healthcare professionals and patients. Some companies in the Alosetron market include GlaxoSmithKline, Novartis, Pfizer, and Sanofi. Show Less Read more